Serial founder and govt with over 30 years of MedTech expertise to steer firm by U.S. medical and industrial growth
Rhythm AI, a MedTech firm centered on optimizing atrial fibrillation (AF) procedures and developer of the STAR Apollo™ Mapping Software program, introduced the appointment of Mike Dineen as Chief Government Officer. Dineen brings greater than 30 years of medtech expertise as a founder, operator, and industrial chief, with a confirmed monitor document of advancing cardiovascular applied sciences from early growth by regulatory clearance, market launch, and profitable acquisition.
Dineen joins Rhythm AI at a pivotal second within the firm’s trajectory in the direction of commercialization. The corporate lately introduced receipt of FDA 510(ok) clearance for its STAR Apollo Mapping System that’s appropriate with Johnson & Johnson’s CARTO™ 3 Mapping System, including to its current and beforehand introduced clearance with Abbott’s EnSite™ X EP System. STAR Apollo gives a exact, patient-specific map of the place AF originates by figuring out patterns of activation, enabling physicians to construct ablation methods which can be focused, discrete and environment friendly. With compatibility now established throughout the 2 most generally used 3D mapping platforms in medical apply, Rhythm AI is positioned to speed up its U.S. rollout and develop doctor entry.
Additionally Learn: AIThority Interview With Rohit Agarwal, Founder & CEO of Portkey
“Rhythm AI is at an essential inflection level and Mike brings precisely the mix of expertise and expertise Rhythm AI wants at this stage: deep cardiovascular experience, a monitor document of constructing and scaling commercial-stage medtech corporations, and a real understanding of what electrophysiologists want within the EP lab,” stated Professor Richard Schilling, Founder and Chairman of Rhythm AI.
Previous to becoming a member of Rhythm AI, Dineen served as co-founder and Chief Government Officer of Tioga Cardiovascular, a Shifamed portfolio firm creating a transcatheter mitral valve alternative system. Earlier than Tioga, he was CEO of Kalila Medical, additionally a Shifamed portfolio firm, the place he led the group from early-stage prototype by regulatory approvals, industrial product launch, and a profitable acquisition by Abbott. Previous to Kalila Medical, Dineen held senior management roles at quite a lot of cardiovascular and surgical medtech corporations, together with Vice President of Enterprise Growth at Maya Medical (acquired by Covidien, now Medtronic), Vice President of Advertising at Aragon Surgical (acquired by Aesculap), and Vice President of Advertising at Concentric Medical (acquired by Stryker). Dineen is a named inventor on greater than 60 issued U.S. patents. He holds a B.S. in Biology and an M.B.A. from Santa Clara College.
“In three many years in MedTech, I’ve discovered to acknowledge when a know-how is actually differentiated and STAR Apollo is that know-how: clinically significant, commercially differentiated, and constructed to combine seamlessly into the infrastructure that already exists in EP labs worldwide,” stated Mike Dineen, CEO of Rhythm AI. “My focus shall be to speed up adoption, generate the medical proof that drives broad doctor uptake, and place STAR Apollo because the important intelligence layer for AF ablation globally. Constructing the precise partnerships and industrial infrastructure shall be crucial to attaining that imaginative and prescient and delivering the know-how to the sufferers and physicians who want it most.”
